
Lupin Limited has informed the Exchange regarding a press release dated March 13, 2023, titled "Lupin Bioresearch Centre Completes U.S. FDA Inspection with No Observations.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated March 13, 2023, titled "Lupin Bioresearch Centre Completes U.S. FDA Inspection with No Observations.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin